Insurance-Negotiated Rates Are Not Market Prices
In most markets, insurance exists to reduce financial volatility, not to determine the underlying price of goods and services. Healthcare is an exception. Here, insurance does not simply pay for care—it plays a central role in how prices are set. Across many outpatient and routine services, prices paid under insurance are frequently 40–60% higher than cash or self-pay rates, reflecting differences in payment structure rather than differences in care.
For routine and semi-routine medical services, the prices paid under insurance are typically insurance-negotiated rates, not market prices. These rates are established through complex negotiations between insurers and providers, anchored to inflated baseline charges and shaped by administrative requirements, delayed payment, and regulatory compliance. As a result, they often bear little resemblance to the actual cost of delivering care.
At the same time, many of these same services are available at lower prices when paid for directly. Cash or self-pay transactions bypass much of the administrative friction embedded in insurance billing and allow providers to accept immediate, predictable payment. The difference is not cosmetic—it reflects fundamentally different economic conditions under which prices are formed.
Why Insurance Inflates the Price of Routine Care
Higher prices under insurance are not primarily the result of better care or stronger negotiation. They are the predictable outcome of how third-party payment reshapes incentives and workflows throughout the system.
When care is billed through insurance, providers must account for non-clinical costs such as coding requirements, prior authorizations, claim denials, delayed reimbursement, and compliance obligations. These costs are real, recurring, and unavoidable for in-network participation—and they are embedded directly into negotiated rates.
Insurance pricing is also anchored to artificially elevated charge structures. Discounts are negotiated relative to these baselines, but the resulting prices frequently remain well above what the same services command in direct-pay settings. In this environment, negotiation does not function as price discovery; it functions as a mechanism for allocating administrative burden across payers and providers. The effort it takes for a provider to get paid in an insurance setting is relatively high and must be accounted for in their rates.
The key point is not that insurance is inefficient by accident, but that it is doing what it was designed to do: manage risk, compliance, and complexity at scale. The higher prices associated with insurance reflect those functions—not a more expensive form of medicine.
Providers Are Already Responding
These pricing dynamics are not theoretical. In recent years, an increasing number of clinicians and outpatient practices have chosen to limit or eliminate participation in insurance networks altogether.
This trend is most visible in primary care, preventive medicine, and specialty outpatient services, where providers report that administrative burden, payment uncertainty, and constraints on clinical autonomy outweigh the benefits of insurance participation. By operating outside insurance frameworks, many are able to reduce overhead, simplify care delivery, and offer patients clearer, often lower, prices.
The significance of this shift is not that insurance is disappearing, but that dual pricing may not represent a stable equilibrium. When providers consistently find that care can be delivered more efficiently outside insurance-driven price formation, their behavior signals structural strain within the prevailing model.
Why FLOW Costs Cannot Be Compared to Insurance-Based Costs
These dynamics have an important implication for how healthcare costs should be evaluated under alternative financing models like FLOW.
FLOW does not reduce costs by negotiating harder or limiting care. It takes advantage of the fact that many healthcare services are already available at materially lower prices when paid for directly. By structuring routine care around these lower-priced service channels, total spending under FLOW should be lower on average than spending on comparable services paid for under insurance-negotiated rates.
Insurance retains a critical role under FLOW, but a narrower and more appropriate one. It is reserved for low-probability, high-severity events—hospitalization, catastrophic illness, and other unpredictable, high-cost scenarios—where risk pooling is economically justified, as is the complexity of claims processing and the resulting higher rates.
This distinction matters when comparing costs. Historic healthcare spending data reflects prices formed under insurance-based financing, not the underlying cost of care itself. Comparing FLOW spending directly to historic insurance-funded consumption is therefore not a like-for-like exercise. The prices being paid are different.
Under FLOW, apparent savings arise not from reduced utilization, but from accessing services at prices closer to their true economic cost. FLOW does not attempt to pay today’s healthcare prices more efficiently—it operates on a different price basis altogether, one that removes insurance from routine price formation and reassigns it to the role it performs best.
